Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | -16.67% | 0.00% | 0.00% |
08/05 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
05/03 | Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
0.00% | 21.27M | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+43.45% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- IVX Stock
- News Invion Limited
- Invion Validates Efficacy of Photodynamic Drug Against Anal Cancer